Global pharmaceutical CRO market will reach $104.4 billion by 2030, growing by 8.1% annually over 2020-2030 driven by the increasing incidence of disease, rising healthcare expenditures, increasing dependence on contract research organizations due to improved efficiency and productivity.
Highlighted with 85 tables and 77 figures, this 168-page report “Global Pharmaceutical Contract Research Organization (CRO) Market 2020-2030 by Service, Therapeutic Application, End User, and Region: Trend Forecast and Growth Opportunity” is based on a comprehensive research of the entire global pharmaceutical CRO market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2015-2019 and provides forecast from 2020 till 2030 with 2019 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
In-depth qualitative analyses include identification and investigation of the following aspects:
• Market Structure
• Growth Drivers
• Restraints and Challenges
• Emerging Product Trends & Market Opportunities
• Porter’s Fiver Forces
The trend and outlook of global market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19. The balanced (most likely) projection is used to quantify global pharmaceutical CRO market in every aspect of the classification from perspectives of Service, Therapeutic Application, End User, and Region.
Based on Service, the global market is segmented into the following sub-markets with annual revenue for 2019-2030 included in each section.
• CRO for Pre-clinical Development
• CRO for Phase I Trials
• CRO for Phase II Trials
• CRO for Phase III Trials
• CRO for Phase IV Trials
• Laboratory Services
• Consulting Services
• Data Management Services
Based on Therapeutic Application, the global market is segmented into the following sub-markets with annual revenue for 2019-2030 included in each section.
• Infectious Diseases
• Oncology
• Metabolic Disorders
• Cardiovascular Disorders
• Central Nervous System
• Respiratory Disorders
• Gastrointestinal Disorders
• Other Therapeutic Applications
Based on End User, the global market is segmented into the following sub-markets with annual revenue for 2019-2030 included in each section.
• Pharmaceutical & Biopharmaceutical Companies
• Medical Device Companies
• Academic Institutes
Geographically, the following regions together with the listed national/local markets are fully investigated:
• APAC (Japan, China, South Korea, Australia, India, and Rest of APAC; Rest of APAC is further segmented into Malaysia, Singapore, Indonesia, Thailand, New Zealand, Vietnam, Taiwan, and Philippines)
• Europe (Germany, UK, France, Spain, Italy, Russia, Rest of Europe; Rest of Europe is further segmented into Netherlands, Switzerland, Turkey, Poland, Sweden, Belgium, Austria, Ireland, Norway, Denmark, and Finland)
• North America (U.S., Canada, and Mexico)
• South America (Brazil, Chile, Argentina, Rest of South America)
• MEA (Saudi Arabia, UAE, South Africa)
For each aforementioned region and country, detailed analysis and data for annual revenue are available for 2019-2030. The breakdown of all regional markets by country and split of key national markets by Service, Therapeutic Application, and End User over the forecast years are also included.
The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.
Specifically, potential risks associated with investing in global pharmaceutical CRO market are assayed quantitatively and qualitatively through GMD’s Risk Assessment System. According to the risk analysis and evaluation, Critical Success Factors (CSFs) are generated as a guidance to help investors & stockholders identify emerging opportunities, manage and minimize the risks, develop appropriate business models, and make wise strategies and decisions.
Key Players (this may not be a complete list and extra companies can be added upon request):
Charles River Laboratories
CMIC Co. Ltd
Covance Inc.
Hangzhou Tigermed Consulting Co Ltd
ICON Plc
IQVIA Holdings Inc.
LSK Global Pharma Service Co Ltd
Novotech Pty Ltd
PAREXEL International Corporation
Pharmaceutical Product Development LLC (PPD)
PRA Health Sciences Inc.
Quanticate Ltd
Samsung Bioepis Co. Ltd
SGS SA (SGS Life Sciences)
Syneos Health Inc.
WuXi AppTec Inc.
(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
Table of Contents
1 Introduction 8
1.1 Industry Definition and Research Scope 8
1.1.1 Industry Definition 8
1.1.2 Research Scope 9
1.2 Research Methodology 12
1.2.1 Overview of Market Research Methodology 12
1.2.2 Market Assumption 13
1.2.3 Secondary Data 13
1.2.4 Primary Data 13
1.2.5 Data Filtration and Model Design 15
1.2.6 Market Size/Share Estimation 16
1.2.7 Research Limitations 17
1.3 Executive Summary 18
2 Market Overview and Dynamics 21
2.1 Market Size and Forecast 21
2.1.1 Impact of COVID-19 on World Economy 22
2.1.2 Impact of COVID-19 on the Market 25
2.2 Major Growth Drivers 27
2.3 Market Restraints and Challenges 32
2.4 Emerging Opportunities and Market Trends 35
2.5 Porter’s Fiver Forces Analysis 39
3 Segmentation of Global Market by Service 43
3.1 Market Overview by Service 43
3.2 CRO for Pre-clinical Development 45
3.3 CRO for Phase I Trials 46
3.4 CRO for Phase II Trials 47
3.5 CRO for Phase III Trials 48
3.6 CRO for Phase IV Trials 49
3.7 Laboratory Services 50
3.8 Consulting Services 51
3.9 Data Management Services 52
4 Segmentation of Global Market by Therapeutic Application 53
4.1 Market Overview by Therapeutic Application 53
4.2 Infectious Diseases 55
4.3 Oncology 56
4.4 Metabolic Disorders 57
4.5 Cardiovascular Disorders 58
4.6 Central Nervous System 59
4.7 Respiratory Disorders 60
4.8 Gastrointestinal Disorders 61
4.9 Other Therapeutic Applications 62
5 Segmentation of Global Market by End User 63
5.1 Market Overview by End User 63
5.2 Pharmaceutical & Biopharmaceutical Companies 65
5.3 Medical Device Companies 66
5.4 Academic Institutes 67
6 Segmentation of Global Market by Region 69
6.1 Geographic Market Overview 2019-2030 69
6.2 North America Market 2019-2030 by Country 73
6.2.1 Overview of North America Market 73
6.2.2 U.S. 77
6.2.3 Canada 81
6.2.4 Mexico 83
6.3 European Market 2019-2030 by Country 85
6.3.1 Overview of European Market 85
6.3.2 Germany 89
6.3.3 UK 91
6.3.4 France 93
6.3.5 Spain 95
6.3.6 Italy 97
6.3.7 Russia 99
6.3.8 Rest of European Market 101
6.4 Asia-Pacific Market 2019-2030 by Country 103
6.4.1 Overview of Asia-Pacific Market 103
6.4.2 Japan 107
6.4.3 China 110
6.4.4 Australia 112
6.4.5 India 114
6.4.6 South Korea 116
6.4.7 Rest of APAC Region 118
6.5 South America Market 2019-2030 by Country 120
6.5.1 Argentina 123
6.5.2 Brazil 125
6.5.3 Chile 127
6.5.4 Rest of South America Market 129
6.6 MEA Market 2019-2030 by Country 130
6.6.1 UAE 133
6.6.2 Saudi Arabia 135
6.6.3 South Africa 137
6.6.4 Other National Markets 139
7 Competitive Landscape 140
7.1 Overview of Key Vendors 140
7.2 New Product Launch, Partnership, Investment, and M&A 144
7.3 Company Profiles 145
Charles River Laboratories 145
CMIC Co. Ltd 147
Covance Inc. 148
Hangzhou Tigermed Consulting Co Ltd 149
ICON Plc 150
IQVIA Holdings Inc. 151
LSK Global Pharma Service Co Ltd 152
Novotech Pty Ltd 153
PAREXEL International Corporation 154
Pharmaceutical Product Development LLC (PPD) 155
PRA Health Sciences Inc. 156
Quanticate Ltd 157
Samsung Bioepis Co. Ltd 158
SGS SA (SGS Life Sciences) 159
Syneos Health Inc. 160
WuXi AppTec Inc. 161
8 Investing in Global Market: Risk Assessment and Management 162
8.1 Risk Evaluation of Global Market 162
8.2 Critical Success Factors (CSFs) 165
Related Reports and Products 168
Table 1. Snapshot of Global Pharmaceutical CRO Market in Balanced Perspective, 2019-2030 19
Table 2. Growth Rate of World Real GDP, 2017-2021 23
Table 3. World Top 10 Pharmaceutical Companies Based on Projected R&D Spending in 2026, $ bn 29
Table 4. Worldwide Total Number of Registered Clinical Trials 31
Table 5. Main Product Trends and Market Opportunities in Global Pharmaceutical CRO Market 35
Table 6. Global Pharmaceutical CRO Market by Service, 2019-2030, $ bn 43
Table 7. Global Pharmaceutical CRO Market by Therapeutic Application, 2019-2030, $ bn 53
Table 8. Global Pharmaceutical CRO Market by End User, 2019-2030, $ bn 63
Table 9. Global Pharmaceutical CRO Market by Region, 2019-2030, $ bn 70
Table 10. Leading National Pharmaceutical CRO Market, 2019 and 2030, $ bn 72
Table 11. North America Pharmaceutical CRO Market by Country, 2019-2030, $ bn 75
Table 12. U.S. Pharmaceutical CRO Market by Service, 2019-2030, $ bn 79
Table 13. U.S. Pharmaceutical CRO Market by Therapeutic Application, 2019-2030, $ bn 79
Table 14. U.S. Pharmaceutical CRO Market by End User, 2019-2030, $ bn 79
Table 15. Canada Pharmaceutical CRO Market by Service, 2019-2030, $ bn 82
Table 16. Canada Pharmaceutical CRO Market by Therapeutic Application, 2019-2030, $ bn 82
Table 17. Canada Pharmaceutical CRO Market by End User, 2019-2030, $ bn 82
Table 18. Mexico Pharmaceutical CRO Market by Service, 2019-2030, $ bn 84
Table 19. Mexico Pharmaceutical CRO Market by Therapeutic Application, 2019-2030, $ bn 84
Table 20. Mexico Pharmaceutical CRO Market by End User, 2019-2030, $ bn 84
Table 21. Europe Pharmaceutical CRO Market by Country, 2019-2030, $ bn 88
Table 22. Germany Pharmaceutical CRO Market by Service, 2019-2030, $ bn 90
Table 23. Germany Pharmaceutical CRO Market by Therapeutic Application, 2019-2030, $ bn 90
Table 24. Germany Pharmaceutical CRO Market by End User, 2019-2030, $ bn 90
Table 25. UK Pharmaceutical CRO Market by Service, 2019-2030, $ bn 92
Table 26. UK Pharmaceutical CRO Market by Therapeutic Application, 2019-2030, $ bn 92
Table 27. UK Pharmaceutical CRO Market by End User, 2019-2030, $ bn 92
Table 28. France Pharmaceutical CRO Market by Service, 2019-2030, $ bn 94
Table 29. France Pharmaceutical CRO Market by Therapeutic Application, 2019-2030, $ bn 94
Table 30. France Pharmaceutical CRO Market by End User, 2019-2030, $ bn 94
Table 31. Spain Pharmaceutical CRO Market by Service, 2019-2030, $ bn 96
Table 32. Spain Pharmaceutical CRO Market by Therapeutic Application, 2019-2030, $ bn 96
Table 33. Spain Pharmaceutical CRO Market by End User, 2019-2030, $ bn 96
Table 34. Italy Pharmaceutical CRO Market by Service, 2019-2030, $ bn 98
Table 35. Italy Pharmaceutical CRO Market by Therapeutic Application, 2019-2030, $ bn 98
Table 36. Italy Pharmaceutical CRO Market by End User, 2019-2030, $ bn 98
Table 37. Russia Pharmaceutical CRO Market by Service, 2019-2030, $ bn 100
Table 38. Russia Pharmaceutical CRO Market by Therapeutic Application, 2019-2030, $ bn 100
Table 39. Russia Pharmaceutical CRO Market by End User, 2019-2030, $ bn 100
Table 40. Pharmaceutical CRO Market in Rest of Europe by Country, 2019-2030, $ bn 102
Table 41. APAC Pharmaceutical CRO Market by Country, 2019-2030, $ bn 105
Table 42. Japan Pharmaceutical CRO Market by Service, 2019-2030, $ bn 109
Table 43. Japan Pharmaceutical CRO Market by Therapeutic Application, 2019-2030, $ bn 109
Table 44. Japan Pharmaceutical CRO Market by End User, 2019-2030, $ bn 109
Table 45. China Pharmaceutical CRO Market by Service, 2019-2030, $ bn 111
Table 46. China Pharmaceutical CRO Market by Therapeutic Application, 2019-2030, $ bn 111
Table 47. China Pharmaceutical CRO Market by End User, 2019-2030, $ bn 111
Table 48. Australia Pharmaceutical CRO Market by Service, 2019-2030, $ bn 113
Table 49. Australia Pharmaceutical CRO Market by Therapeutic Application, 2019-2030, $ bn 113
Table 50. Australia Pharmaceutical CRO Market by End User, 2019-2030, $ bn 113
Table 51. India Pharmaceutical CRO Market by Service, 2019-2030, $ bn 115
Table 52. India Pharmaceutical CRO Market by Therapeutic Application, 2019-2030, $ bn 115
Table 53. India Pharmaceutical CRO Market by End User, 2019-2030, $ bn 115
Table 54. South Korea Pharmaceutical CRO Market by Service, 2019-2030, $ bn 117
Table 55. South Korea Pharmaceutical CRO Market by Therapeutic Application, 2019-2030, $ bn 117
Table 56. South Korea Pharmaceutical CRO Market by End User, 2019-2030, $ bn 117
Table 57. Pharmaceutical CRO Market in Rest of APAC by Country, 2019-2030, $ bn 119
Table 58. South America Pharmaceutical CRO Market by Country, 2019-2030, $ bn 122
Table 59. Argentina Pharmaceutical CRO Market by Service, 2019-2030, $ bn 124
Table 60. Argentina Pharmaceutical CRO Market by Therapeutic Application, 2019-2030, $ bn 124
Table 61. Argentina Pharmaceutical CRO Market by End User, 2019-2030, $ bn 124
Table 62. Brazil Pharmaceutical CRO Market by Service, 2019-2030, $ bn 126
Table 63. Brazil Pharmaceutical CRO Market by Therapeutic Application, 2019-2030, $ bn 126
Table 64. Brazil Pharmaceutical CRO Market by End User, 2019-2030, $ bn 126
Table 65. Chile Pharmaceutical CRO Market by Service, 2019-2030, $ bn 128
Table 66. Chile Pharmaceutical CRO Market by Therapeutic Application, 2019-2030, $ bn 128
Table 67. Chile Pharmaceutical CRO Market by End User, 2019-2030, $ bn 128
Table 68. MEA Pharmaceutical CRO Market by Country, 2019-2030, $ bn 132
Table 69. UAE Pharmaceutical CRO Market by Service, 2019-2030, $ bn 134
Table 70. UAE Pharmaceutical CRO Market by Therapeutic Application, 2019-2030, $ bn 134
Table 71. UAE Pharmaceutical CRO Market by End User, 2019-2030, $ bn 134
Table 72. Saudi Arabia Pharmaceutical CRO Market by Service, 2019-2030, $ bn 136
Table 73. Saudi Arabia Pharmaceutical CRO Market by Therapeutic Application, 2019-2030, $ bn 136
Table 74. Saudi Arabia Pharmaceutical CRO Market by End User, 2019-2030, $ bn 136
Table 75. South Africa Pharmaceutical CRO Market by Service, 2019-2030, $ bn 138
Table 76. South Africa Pharmaceutical CRO Market by Therapeutic Application, 2019-2030, $ bn 138
Table 77. South Africa Pharmaceutical CRO Market by End User, 2019-2030, $ bn 138
Table 78. Breakdown of Global Market by Key Vendor, 2019, % 142
Table 79. Charles River Laboratories: Company Snapshot 145
Table 80. Charles River Laboratories: Business Segmentation 145
Table 81. Charles River Laboratories: Product Portfolio 146
Table 82. Charles River Laboratories: Revenue, 2016-2018, $ bn 146
Table 83. Charles River Laboratories: Recent Developments 146
Table 84. Risk Evaluation for Investing in Global Market, 2019-2030 163
Table 85. Critical Success Factors and Key Takeaways 166
